WEALTH ENHANCEMENT ADVISORY SERVICES, LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1632972
PLYMOUTH, MN
Position in GILD
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$76,288,640
+$8,029,396 QoQ
Shares Held
603,836
+23.3% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#168
of 2,265 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 4%
Shared 0%
None 96%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $1,542,735,587 across 15 Drug Manufacturers - General names. GILD ranks #7 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,833,813 | $465,733,487 | |
| 2 | LLY |
ELI LILLY & Co
|
183,702 | $220,337,708 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,625,531 | $208,880,733 | |
| 4 | AMGN |
Amgen Inc
|
464,220 | $168,103,346 | |
| 5 | ABBV |
AbbVie Inc.
|
576,543 | $145,081,280 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,764,695 | $101,681,725 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
603,836 | $76,288,640 | |
| 8 | PFE |
Pfizer Inc
|
3,158,575 | $76,058,486 |
All Filings in GILD
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $76,288,640 | 603,836 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $68,259,244 | 489,770 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $77,717,126 | 633,185 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $66,071,196 | 595,236 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $53,663,075 | 484,018 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $32,826,840 | 292,966 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $25,842,539 | 279,772 | Shares | Sole | 2025-03-17 | |
| 2024-09-30 | $27,081,242 | 323,011 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $19,630,418 | 286,116 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $18,528,880 | 252,954 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $21,356,585 | 263,629 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $16,121,092 | 215,120 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,331,950 | 56,208 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $4,639,516 | 55,918 | Shares | Sole | 2023-04-25 | |
| 2022-03-31 | $6,100,640 | 102,618 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $7,004,541 | 96,468 | Shares | Sole | 2022-02-08 | |
| 2020-03-31 | $1,254,771 | 16,784 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||